1. Schuppan D, Afdhal NH (2008) Liver cirrhosis. Lancet 371:838–851.
2. Snyder N, Gajula L, Xiao SY et al (2006) APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C. J ClinGastroenterol 40:535–542.
3. Scaglione S, Kliethermes S, Cao G, Shoham D, Durazo R, Luke A, Volk ML (2015) The epidemiology of cirrhosis in the United States: a population-based study. J ClinGastroenterol 49(8):690–696.
4. Sebastiani G, Castera L, Halfon P, Pol S, Mangia A, Di Marco V et al (2011) The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. Aliment Pharmacol Ther. 34:1202–1216. https://doi.org/10.1111/j.1365-2036.2011.04861.x.
5. Zhao Y, Ren M, Lu G, Lu X, Yin Y, Zhang D et al (2020) The prognosis analysis of liver cirrhosis with acute variceal bleeding and validation of current prognostic models: a large-scale retrospective cohort study. BioMed Res Int 2020:7372868.